Management of Ovarian Mass with Fecaloid Ascites
The management of an ovarian mass with fecaloid ascites requires immediate surgical intervention with comprehensive staging and cytoreductive surgery by a gynecologic oncologist, as this presentation strongly suggests advanced ovarian malignancy with possible bowel involvement or perforation. 1
Initial Evaluation
- Patients with ovarian masses and ascites typically present with abdominal distention, bloating, early satiety, nausea, and changes in bowel habits 1, 2
- The presence of fecaloid ascites specifically suggests:
- Initial workup should include:
- Comprehensive imaging with CT scan of abdomen/pelvis to assess the extent of disease 1
- Tumor markers including CA-125, CEA, and CA 19-9 (elevated CEA may suggest gastrointestinal origin or primary mucinous ovarian tumor) 1
- Assessment of nutritional status, as poor nutrition is associated with increased infectious complications 3
Surgical Management
- Immediate exploratory laparotomy is indicated due to the high risk of peritonitis and sepsis from fecal contamination 1, 3
- The surgical approach should include:
- Midline vertical incision to allow adequate access to the upper abdomen 1
- Aspiration of ascitic fluid for cytologic examination and culture 1
- Comprehensive assessment of all peritoneal surfaces 1
- Total hysterectomy, bilateral salpingo-oophorectomy, and omentectomy 1
- Inspection and possible resection of involved bowel segments 1, 3
- Maximal cytoreduction with goal of no residual disease 1
- Pelvic and para-aortic lymph node dissection extending to the level of the renal vessels 1, 4
- Peritoneal washing and thorough irrigation of the abdominal cavity 1, 3
Special Considerations
- Preoperative mechanical bowel preparation should be performed if possible, as it significantly reduces infectious morbidity (p=0.01) 3
- Nutritional optimization is critical, as poor nutritional status is associated with increased infectious complications (p=0.03) 3
- Appendectomy should be performed in all cases of mucinous tumors to rule out appendiceal primary 1
- Consider placement of intraperitoneal catheter for potential postoperative intraperitoneal chemotherapy in patients with minimal residual disease 1
- Careful evaluation of the gastrointestinal tract is essential to rule out a primary gastrointestinal malignancy with ovarian metastases, particularly for mucinous tumors 1
Postoperative Management
- Broad-spectrum antibiotics covering gram-negative and anaerobic organisms should be administered 3
- Close monitoring for signs of peritonitis, sepsis, or postoperative bowel obstruction 3, 5
- Staging based on surgical findings will guide adjuvant therapy 1
- Patients with ascites and ovarian masses have a 95% positive predictive value for malignancy 6
Prognostic Considerations
- FIGO staging remains the most powerful indicator of prognosis 1
- The presence of ascites correlates with advanced stage disease - 89% of advanced stage (III and IV) ovarian cancers produce ascites, compared to only 17% of early stage disease 6
- The volume of ascites also correlates with stage - the majority (66%) of patients with stage III and IV disease have >0.5 liters of ascites 6
Common Pitfalls to Avoid
- Delaying surgical intervention when fecaloid ascites is present, as this increases risk of sepsis and mortality 3
- Attributing persistent bloating to functional gastrointestinal disorders without excluding ovarian pathology 2
- Dismissing the possibility of malignancy in the presence of normal CA-125, as early-stage disease may have normal levels in up to 50% of cases 2
- Failing to perform comprehensive surgical staging, which occurs in approximately 90% of apparent early-stage ovarian cancer cases in the United States 1